{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T11:03:21Z","timestamp":1784027001725,"version":"3.55.0"},"reference-count":117,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100014177","name":"The Legacy of Angels Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014177","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.ymgme.2021.08.008","type":"journal-article","created":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T10:52:07Z","timestamp":1629543127000},"page":"8-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Challenging the dogma of the healthy heterozygote: Implications for newborn screening policies and practices"],"prefix":"10.1016","volume":"134","author":[{"given":"Philip M.","family":"Farrell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elinor","family":"Langfelder-Schwind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ymgme.2021.08.008_bb0005","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3390\/ijns4040039","article-title":"Newborn screening for sickle cell disease and other hemoglobinopathies: a short review on classical laboratory methods-isoelectric focusing, HPLC, and capillary electrophoresis","volume":"4","author":"Fr\u00f6mmel","year":"2018","journal-title":"Int. J. Neonatal Screen"},{"issue":"22","key":"10.1016\/j.ymgme.2021.08.008_bb0010","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1182\/blood-2018-06-848705","article-title":"The current state of sickle cell trait: implications for reproductive and genetic counseling","volume":"32","author":"Pecker","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2021.08.008_bb0015","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1073\/pnas.1914912117","article-title":"Cystic fibrosis carriers are at increased risk for a wide range of cystic fibrosis-related conditions","volume":"117","author":"Miller","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0020","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1093\/hmg\/8.12.2247","article-title":"Genetic epidemiology of the carnitine transporter OCTN2 gene in a Japanese population and phenotypic characterization in Japanese pedigrees with primary systemic carnitine deficiency","volume":"8","author":"Koizumi","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0025","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1023\/A:1022487218904","article-title":"The clinical syndrome of creatine transporter deficiency","volume":"244","author":"DeGrauw","year":"2003","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0030","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1056\/NEJM199506013322204","article-title":"Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens","volume":"332","author":"Chillon","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0035","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1203\/00006450-197912000-00011","article-title":"Hormonal phenotype and HLA-genotype in families of patients with congenital adrenal hyperplasia (21-hydroxylase deficiency)","volume":"13","author":"Lorenzen","year":"1979","journal-title":"Pediatr. Res."},{"issue":"7","key":"10.1016\/j.ymgme.2021.08.008_bb0040","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/s41436-020-0779-4","article-title":"X-linked diseases: susceptible females","volume":"22","author":"Migeon","year":"2020","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0045","first-page":"1616","article-title":"The incidence of alkaptonuria: a study in chemical individuality. 1902","author":"Garrod","year":"1996","journal-title":"Mol. Med."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0050","series-title":"Experiments on Plant Hybridization. Negotiations of the Natural Research Association in Brno","first-page":"3","article-title":"The Full Breadth of Mendel's Genetics, Genetics 204 (4) (2016) 1327\u20131336, [description of Mendel, G., Versuche \u00fcber Pflanzen-Hybriden. Verhandlungen des naturforschenden Vereines in Br\u00fcnn 4 (1866) 3\u201347","volume":"4","author":"van Dijk","year":"1866"},{"issue":"7\u20138","key":"10.1016\/j.ymgme.2021.08.008_bb0055","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.crvi.2016.04.006","article-title":"Beyond the simplicity of mendelian inheritance","volume":"339","author":"Schacherer","year":"2016","journal-title":"C R Biol."},{"issue":"25","key":"10.1016\/j.ymgme.2021.08.008_bb0060","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJM198606193142501","article-title":"Prophylaxis with oral penicillin in children with sickle cell anemia.A randomized trial","volume":"314","author":"Gaston","year":"1986","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.ymgme.2021.08.008_bb0065","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ajh.21699","article-title":"Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia and MSH Patients' Follow-Up: the risks and benefits of long-term use of hydroxyurea in sickle cell anemia: a 17.5 year follow-up","volume":"85","author":"Steinberg","year":"2010","journal-title":"Am. J. Hematol."},{"issue":"9","key":"10.1016\/j.ymgme.2021.08.008_bb0070","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/oxfordjournals.aje.a010288","article-title":"Sickle hemoglobin (HbS) allele and sickle cell disease: a HuGE review","volume":"151","author":"Ashley-Koch","year":"2000","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0075","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/j.semperi.2009.12.006","article-title":"History and current status of newborn screening for hemoglobinopathies","volume":"34","author":"Benson","year":"2010","journal-title":"Semin. Perinatol."},{"issue":"3","key":"10.1016\/j.ymgme.2021.08.008_bb0080","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1053\/j.semperi.2015.03.008","article-title":"Newborn screening for sickle cell diseases in the United States: a review of data spanning 2 decades","volume":"39","author":"Therrell","year":"2015","journal-title":"Semin. Perinatol."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0090","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.1.4857.290","article-title":"Protection afforded by sickle-cell trait against subtertian malarial infection","volume":"1","author":"Allison","year":"1954","journal-title":"Br. Med. J."},{"issue":"1","key":"10.1016\/j.ymgme.2021.08.008_bb0095","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1182\/asheducation-2015.1.160","article-title":"Sickle cell trait diagnosis: clinical and social implications","volume":"2015","author":"Naik","year":"2015","journal-title":"Hematology"},{"key":"10.1016\/j.ymgme.2021.08.008_bb0100","article-title":"Outcome of pregnancy in a population of Nigerian women with sickle cell trait","volume":"26","author":"Adeyemi","year":"2006","journal-title":"J. Obstet. Gynaecol. (Lahore)"},{"issue":"3","key":"10.1016\/j.ymgme.2021.08.008_bb0105","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s40615-014-0077-4","article-title":"Sickle cell trait from a metabolic, renal, and vascular perspective: linking history, knowledge, and health","volume":"2","author":"Thoreson","year":"2015","journal-title":"J. Racial Ethn. Health Disparities"},{"key":"10.1016\/j.ymgme.2021.08.008_bb0110","doi-asserted-by":"crossref","DOI":"10.1056\/NEJM197905033001801","article-title":"Clinical implications of sickle-cell trait and glucose-6-phosphate dehydrogenase deficiency in hospitalized black male patients","volume":"300","author":"Heller","year":"1979","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.ymgme.2021.08.008_bb0115","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1111\/j.1556-4029.2011.01774.x","article-title":"Sickle cell trait-associated deaths: a case series with a review of the literature","volume":"56","author":"Thogmartin","year":"2011","journal-title":"J. Forensic Sci."},{"issue":"5","key":"10.1016\/j.ymgme.2021.08.008_bb0120","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1056\/NEJMoa1516257","article-title":"Sickle cell trait, rhabdomyolysis, and mortality among U.S. army soldiers","volume":"375","author":"Nelson","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.amepre.2011.09.014","article-title":"Ohene-Frempong, screening U.S. college athletes for their sickle cell disease carrier status","volume":"41","author":"Jordan","year":"2011","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0130","doi-asserted-by":"crossref","DOI":"10.1007\/s10897-017-0107-6","article-title":"Perspectives and practices of athletic trainers and team physicians implementing the 2010 NCAA sickle cell trait screening policy","volume":"26","author":"McDonald","year":"2017","journal-title":"J. Genet. Couns."},{"issue":"3","key":"10.1016\/j.ymgme.2021.08.008_bb0135","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/1941738120915690","article-title":"Sudden death associated with sickle cell trait before and after mandatory screening","volume":"12","author":"Buchanan","year":"2020","journal-title":"Sports Health"},{"issue":"20","key":"10.1016\/j.ymgme.2021.08.008_bb0140","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1001\/jama.2014.15063","article-title":"Association of sickle cell trait with chronic kidney disease and albuminuria in african americans","volume":"312","author":"Naik","year":"2014","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ymgme.2021.08.008_bb0145","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1681\/ASN.2019050502","article-title":"Kidney function decline among Black patients with sickle cell trait and sickle cell disease: an observational cohort study","volume":"31","author":"Olaniran","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.ymgme.2021.08.008_bb0150","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/jth.12787","article-title":"Prospective study of sickle cell trait and venous thromboembolism incidence","volume":"13","author":"Folsom","year":"2015","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0155","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2018.206060","article-title":"The carrier state for sickle cell disease is not completely harmless","volume":"104","author":"Xu","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.ymgme.2021.08.008_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.jelectrocard.2019.04.010","article-title":"Association of sickle cell trait with atrial fibrillation: the REGARDS cohort","volume":"55","author":"Douce","year":"2019","journal-title":"J. Electrocardiol."},{"issue":"1","key":"10.1016\/j.ymgme.2021.08.008_bb0165","doi-asserted-by":"crossref","first-page":"e2030435","DOI":"10.1001\/jamanetworkopen.2020.30435","article-title":"Association of sickle cell trait with incidence of coronary heart disease among African American individuals","volume":"4","author":"Hyacinth","year":"2021","journal-title":"JAMA Netw. Open"},{"issue":"2","key":"10.1016\/j.ymgme.2021.08.008_bb0170","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000496058","article-title":"Cardiovascular outcomes in African Americans with sickle cell trait and chronic kidney disease","volume":"49","author":"Olaniran","year":"2019","journal-title":"Am. J. Nephrol."},{"issue":"12","key":"10.1016\/j.ymgme.2021.08.008_bb0175","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/ajh.25615","article-title":"Thirty-year risk of ischemic stroke in individuals with sickle cell trait and modification by chronic kidney disease: the atherosclerosis risk in communities (ARIC) study","volume":"94","author":"Caughey","year":"2019","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0180","doi-asserted-by":"crossref","DOI":"10.2215\/CJN.12100720","article-title":"Effect of sickle cell trait and APOL1 genotype on the association of soluble uPAR with kidney function measures in black Americans","volume":"16","author":"Reiner","year":"2021","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007293","article-title":"Common a-globin variants modify hematologic and other clinical phenotypes in sickle cell trait and disease","volume":"14","author":"Raffield","year":"2018","journal-title":"PLoS Genet."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2021.08.008_bb0190","article-title":"The risk of pregnancy related hypertension disorder associated with sickle cell trait in U.S. service women","volume":"185","author":"O'Hara","year":"2020","journal-title":"Mil. Med."},{"issue":"4","key":"10.1016\/j.ymgme.2021.08.008_bb0195","doi-asserted-by":"crossref","first-page":"e346","DOI":"10.1055\/s-0039-1695743","article-title":"Adverse pregnancy outcomes in women with sickle cell trait","volume":"9","author":"Wellenstein","year":"2019","journal-title":"AJP Rep."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0200","unstructured":"The Management of Sickle Cell Disease, National Institutes of Health, National Heart, Lung, and Blood Institute Division of Blood Diseases and Resources NIH PUBLICATION NO. 02\u20132117 revised 2002 https:\/\/www.nhlbi.nih.gov\/files\/docs\/guidelines\/sc_mngt.pdf. (accessed 29 May 2021)."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0205","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/1556-4029.12713","article-title":"Sickle cell trait as a contributory cause of death in natural disease","volume":"60","author":"Podduturi","year":"2015","journal-title":"J. Forens. Sci."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0210","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/(SICI)1097-0258(19960315)15:5<449::AID-SIM173>3.0.CO;2-X","article-title":"The incidence of cystic fibrosis","volume":"15","author":"Kosorok","year":"1996","journal-title":"Stat. Med."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0215","unstructured":"S.L. Martiniano A. Elbert P.M. Farrell, et al., Outcomes of infants born during the first 9 years of CF newborn screening in the United States: a retrospective Cystic Fibrosis Foundation Patient Registry cohort study, Pediatr. Pulmonol., in press."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0220","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1126\/science.2570460","article-title":"Identification of the cystic fibrosis gene: genetic analysis","volume":"245","author":"Kerem","year":"1989","journal-title":"Science"},{"issue":"Suppl. 2","key":"10.1016\/j.ymgme.2021.08.008_bb0225","article-title":"Recommendations for the classification of diseases as CFTR-related disorders","volume":"10","author":"Bombieri","year":"2011","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0230","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/ng.2745","article-title":"Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene","volume":"45","author":"Sosnay","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0235","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/humu.10041","article-title":"Cystic fibrosis: a worldwide analysis of CFTR mutations--correlation with incidence data and application to screening","volume":"19","author":"Bobadilla","year":"2002","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0240","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3390\/genes11040401","article-title":"The impact of the CFTR gene discovery on cystic fibrosis diagnosis, counseling, and preventive therapy","volume":"11","author":"Farrell","year":"2020","journal-title":"Genes"},{"key":"10.1016\/j.ymgme.2021.08.008_bb0245","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/ijns6010008","article-title":"History of newborn screening for CF\u2014the early years","volume":"6","author":"Travert","year":"2020","journal-title":"Int. J. Neonatal Screen"},{"key":"10.1016\/j.ymgme.2021.08.008_bb0250","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1542\/peds.113.6.1573","article-title":"Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections","volume":"113","author":"Comeau","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2021.08.008_bb0255","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/01.GIM.0000139506.11694.7C","article-title":"Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel","volume":"6","author":"Watson","year":"2004","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0260","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/humu.22927","article-title":"Clinical sensitivity of cystic fibrosis mutation panels in a diverse population","volume":"37","author":"Hughes","year":"2016","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.107.1.1","article-title":"Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth.\u00a0 Wisconsin Cystic Fibrosis Neonatal Screening Study Group","volume":"107","author":"Farrell","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2021.08.008_bb0270","series-title":"Newborn Screening for Cystic Fibrosis: Evaluation of Benefits and Risks and Recommendations for State Newborn Screening Programs, Morbidity and Mortality Weekly Report, Recommendations and Reports","first-page":"1","volume":"53","author":"Grosse","year":"2004"},{"key":"10.1016\/j.ymgme.2021.08.008_bb0275","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1146\/annurev-genom-083117-021329","article-title":"Cystic fibrosis disease modifiers: complex genetics defines the phenotypic diversity in a monogenic disease","volume":"19","author":"O\u2019Neal","year":"2018","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2016.09.066","article-title":"Cystic fibrosis transmembrane conductance regulator-related metabolic syndrome and cystic fibrosis screen positive, inconclusive diagnosis","volume":"181","author":"Ren","year":"2017","journal-title":"J. Pediatr."},{"issue":"4","key":"10.1016\/j.ymgme.2021.08.008_bb0285","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/ppul.24634","article-title":"Phenotype of children with inconclusive cystic fibrosis diagnosis after newborn screening","volume":"55","author":"Munck","year":"2020","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0290","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jcf.2018.07.008","article-title":"Newborn blood spot screening for cystic fibrosis with a four-step screening strategy in the Netherlands","volume":"18","author":"Dankert-Roelse","year":"2019","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0295","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1749-6632.1962.tb30494.x","article-title":"The eccrine sweat defect in cystic fibrosis of the pancreas (mucoviscidosis)","volume":"93","author":"Sant'Agnese","year":"1962","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0300","first-page":"524","article-title":"Sweat chloride concentrations in infants homozygous or heterozygous for F508 cystic fibrosis","volume":"97","author":"Farrell","year":"1996","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2021.08.008_bb0305","first-page":"911","article-title":"Autonomic and airway reactivity in obligate heterozygotes for cystic fibrosis","volume":"129","author":"Davis","year":"1984","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0310","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/thx.42.2.120","article-title":"Pulmonary abnormalities in obligate heterozygotes for cystic fibrosis","volume":"42","author":"Davis","year":"1987","journal-title":"Thorax"},{"issue":"7295","key":"10.1016\/j.ymgme.2021.08.008_bb0315","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/S0140-6736(63)91926-3","article-title":"The prevalence of respiratory disease in heterozygotes for the gene for fibrocystic disease of the pancreas","volume":"281","author":"Batten","year":"1963","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2021.08.008_bb0320","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1089\/10906570152742317","article-title":"A pilot survey of cystic fibrosis clinical manifestations in CFTR mutation heterozygotes","volume":"5","author":"Castellani","year":"2001","journal-title":"Genet. Test."},{"issue":"5","key":"10.1016\/j.ymgme.2021.08.008_bb0325","first-page":"714","article-title":"Absence of detrimental effect of the carrier state for the cystic fibrosis gene","volume":"92","author":"Hallett","year":"1965","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0330","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jcf.2016.06.001","article-title":"Risk of asthma in heterozygous carriers for cystic fibrosis: a meta-analysis","volume":"15","author":"Nielsen","year":"2016","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0335","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1034\/j.1399-0004.2001.590107.x","article-title":"Prevalence of CFTR mutations in hypertrypsinaemia detected through neonatal screening for cystic fibrosis","volume":"59","author":"Scotet","year":"2001","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0340","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/ajmg.a.30470","article-title":"Cystic fibrosis carriers have higher neonatal immunoreactive trypsinogen values than non-carriers","volume":"135A","author":"Castellani","year":"2005","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0345","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/nur.20452","article-title":"Factors associated with parental perception of child vulnerability 12 months after abnormal newborn screening results","volume":"34","author":"Tluczek","year":"2011","journal-title":"Res. Nurs. Health"},{"key":"10.1016\/j.ymgme.2021.08.008_bb0350","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJM199809033391001","article-title":"Mutations of the cystic fibrosis gene in patients with chronic pancreatitis","volume":"339","author":"Sharer","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0355","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.0009-9163.2004.00265.x","article-title":"Bronchiectasis in adult patients: an expression of heterozygosity for CFTR gene mutations?","volume":"65","author":"Casals","year":"2004","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0360","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/0140-6736(90)92066-Q","article-title":"Abnormal distribution of CF delta F508 allele in azoospermic men with congenital aplasia of epididymis and vas deferens","volume":"336","author":"Dumur","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2021.08.008_bb0365","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1016\/S0140-6736(97)11419-2","article-title":"DeltaF508 heterozygosity in cystic fibrosis and susceptibility to asthma","volume":"351","author":"Dahl","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2021.08.008_bb0370","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1001\/archotol.131.3.237","article-title":"Increased prevalence of chronic rhinosinusitis in carriers of a cystic fibrosis mutation","volume":"131","author":"Wang","year":"2005","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"issue":"3","key":"10.1016\/j.ymgme.2021.08.008_bb0375","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10545-005-7054-3","article-title":"Molecular mechanism of dominant expression in 3-methylcrotonyl-CoA carboxylase deficiency","volume":"28","author":"Baumgartner","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"issue":"12","key":"10.1016\/j.ymgme.2021.08.008_bb0380","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1093\/hmg\/8.12.2247","article-title":"Genetic epidemiology of the carnitine transporter OCTN2 gene in a Japanese population and phenotypic characterization in Japanese pedigrees with primary systemic carnitine deficiency","volume":"8","author":"Koizumi","year":"1999","journal-title":"Hum. Mol. Genet."},{"issue":"48","key":"10.1016\/j.ymgme.2021.08.008_bb0385","doi-asserted-by":"crossref","first-page":"34599","DOI":"10.1074\/jbc.M113.503128","article-title":"Understanding the role of argininosuccinate lyase transcript variants in the clinical and biochemical variability of the urea cycle disorder argininosuccinic aciduria","volume":"288","author":"Hu","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2021.08.008_bb0390","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ymgme.2007.06.010","article-title":"Are heterocygotes for classical homocystinuria at risk of vitamin B12 and folic acid deficiency?","volume":"92","author":"Elsaid","year":"2007","journal-title":"Mol. Genet. Metab."},{"issue":"6","key":"10.1016\/j.ymgme.2021.08.008_bb0395","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.clnu.2014.11.013","article-title":"Heterozygous carriers of classical homocystinuria tend to have higher fasting serum homocysteine concentrations than non-carriers in the presence of folate deficiency","volume":"34","author":"Lu","year":"2015","journal-title":"Clin. Nutr."},{"issue":"4","key":"10.1016\/j.ymgme.2021.08.008_bb0400","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/MOP.0b013e32834726a4","article-title":"Genetic causes of congenital hypothyroidism due to dyshormonogenesis","volume":"23","author":"Grasberger","year":"2011","journal-title":"Curr. Opin. Pediatr."},{"issue":"2","key":"10.1016\/j.ymgme.2021.08.008_bb0405","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s42000-020-00267-x","article-title":"Genetics of primary congenital hypothyroidism-a review","volume":"20","author":"Kostopoulou","year":"2021","journal-title":"Hormones (Athens)"},{"key":"10.1016\/j.ymgme.2021.08.008_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2019.105554","article-title":"Clinical and hormonal characteristics in heterozygote carriers of congenital adrenal hyperplasia","volume":"198","author":"Guarnotta","year":"2020","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"1","key":"10.1016\/j.ymgme.2021.08.008_bb0415","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/03630267909069153","article-title":"Beta 0 thalassemia trait in Sardinia","volume":"3","author":"Galanello","year":"1979","journal-title":"Hemoglobin"},{"issue":"Pt. 3","key":"10.1016\/j.ymgme.2021.08.008_bb0420","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/brain\/awt361","article-title":"X-linked adrenoleukodystrophy in women: a cross-sectional cohort study","volume":"137","author":"Engelen","year":"2014","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.ymgme.2021.08.008_bb0425","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1213\/ane.0b013e3181ad63b4","article-title":"Malignant hyperthermia-like syndrome and carnitine palmitoyltransferase II deficiency with heterozygous R503C mutation","volume":"109","author":"Hogan","year":"2009","journal-title":"Anesth. Analg."},{"issue":"23\u201324","key":"10.1016\/j.ymgme.2021.08.008_bb0430","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00508-012-0296-9","article-title":"Clinically symptomatic heterozygous carnitine palmitoyltransferase II (CPT II) deficiency","volume":"124","author":"Joshi","year":"2012","journal-title":"Wien. Klin. Wochenschr."},{"issue":"1","key":"10.1016\/j.ymgme.2021.08.008_bb0435","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/ana.20320","article-title":"Fuel utilization in subjects with carnitine palmitoyltransferase 2 gene mutations","volume":"57","author":"\u00d8rngreen","year":"2005","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.ymgme.2021.08.008_bb0440","first-page":"429","article-title":"Cataracts in patients heterozygous for galactokinase deficiency","volume":"27","author":"Stambolian","year":"1986","journal-title":"Invest. Ophthalmol.\u00a0Vis Sci."},{"issue":"1","key":"10.1016\/j.ymgme.2021.08.008_bb0445","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jcf.2005.09.008","article-title":"Cystic fibrosis mutations and genotype-pulmonary phenotype analysis","volume":"5","author":"Braun","year":"2006","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0450","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"A CFTR potentiator in patients with cystic fibrosis and the G551D mutation","volume":"365","author":"Ramsey","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0455","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJMoa1807119","article-title":"VX-659\u2013Tezacaftor\u2013Ivacaftor in patients with cystic fibrosis and one or two Phe508del alleles","volume":"379","author":"Davies","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0460","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev.genom.6.080604.162254","article-title":"Modifier genetics: cystic fibrosis","volume":"6","author":"Cutting","year":"2005","journal-title":"Annu. Rev. Genom. Hum. Genet."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0465","doi-asserted-by":"crossref","first-page":"8382","DOI":"10.1038\/ncomms9382","article-title":"Genome-wide association metaanalysis identifies five modifier loci of lung disease severity in cystic fibrosis","volume":"6","author":"Corvol","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0470","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.tcm.2019.02.004","article-title":"Statin therapy for young adults: a long-term investment worth considering","volume":"30","author":"Miedema","year":"2020","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0475","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00198-007-0543-5","article-title":"FRAXTM and the assessment of fracture probability in men and women from the UK","volume":"19","author":"Kanis","year":"2008","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0480","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/35057062","article-title":"Initial sequencing and analysis of the human genome","volume":"409","year":"2001","journal-title":"Nature"},{"issue":"R2","key":"10.1016\/j.ymgme.2021.08.008_bb0485","doi-asserted-by":"crossref","first-page":"R250","DOI":"10.1093\/hmg\/ddy170","article-title":"Physician preparedness for big genomic data: a review of genomic medicine education initiatives in the United States","volume":"27","author":"Rubanovich","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0490","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jpeds.2020.03.027","article-title":"Experience with parent follow-up for communication outcomes after newborn screening identifies carrier status","volume":"224","author":"Farrell","year":"2020","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0495","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0065-3101(24)00075-6","article-title":"Newborn screening: principles and practice","volume":"43","author":"Allen","year":"1996","journal-title":"Adv. Pediatr."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0505","series-title":"Principles of Biomedical Ethics","author":"Beauchamp","year":"2001"},{"key":"10.1016\/j.ymgme.2021.08.008_bb0510","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10897-005-9014-3","article-title":"A new definition of genetic counseling: National Society of Genetic Counselors' Task Force Report","volume":"15","author":"Resta","year":"2006","journal-title":"J. Genet. Couns."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajhg.2020.08.001","article-title":"Genomic sequencing for newborn screening: results of the NC NEXUS project","volume":"107","author":"Roman","year":"2020","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0520","doi-asserted-by":"crossref","DOI":"10.1007\/s10897-017-0067-x","article-title":"A rapid systematic review of outcomes studies in genetic counseling","volume":"26","author":"Madlensky","year":"2017","journal-title":"J. Genet. Couns."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0525","doi-asserted-by":"crossref","DOI":"10.1002\/jgc4.1050","article-title":"The impact of cardiovascular genetic counseling on patient empowerment","volume":"28","author":"Ison","year":"2019","journal-title":"J. Genet. Couns."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0530","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/CRD.0000000000000081","article-title":"A case for inclusion of genetic counselors in cardiac care","volume":"24","author":"Arscott","year":"2016","journal-title":"Cardiol. Rev."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0535","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/jgc4.1098","article-title":"Secondary findings: how did we get here, and where are we going?","volume":"28","author":"Ormond","year":"2019","journal-title":"J. Genet. Couns."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0540","doi-asserted-by":"crossref","DOI":"10.1002\/jgc4.1048","article-title":"Beyond medical actionability: public perceptions of important actions in response to hypothetical genetic testing results","author":"Seiffert","year":"2019","journal-title":"J. Genet. Couns."},{"issue":"4","key":"10.1016\/j.ymgme.2021.08.008_bb0545","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1089\/ham.2014.1034","article-title":"The splenic syndrome in individuals with sickle cell trait","volume":"15","author":"Goodman","year":"2014","journal-title":"High Alt. Med. Biol."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0555","doi-asserted-by":"crossref","DOI":"10.1002\/jgc4.1124","article-title":"Sickle cell carriers' unmet information needs: beyond knowing trait status","volume":"28","author":"Mayo-Gamble","year":"2019","journal-title":"J. Genet. Couns."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0560","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1001\/archpedi.155.2.120","article-title":"Genetic counseling and other risk communication services by newborn screening programs","volume":"155","author":"Farrell","year":"2001","journal-title":"Arch. Pediatr. Adol. Med."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0565","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1542\/peds.2015-0811","article-title":"Newborn screening for cystic fibrosis in California","volume":"136","author":"Kharrazi","year":"2015","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.ymgme.2021.08.008_bb0570","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/jgc4.1170","article-title":"Practice variation of genetic counselor engagement in the cystic fibrosis newborn screen-positive diagnostic resolution process","volume":"28","author":"Langfelder-Schwind","year":"2019","journal-title":"J. Genet. Couns."},{"issue":"5","key":"10.1016\/j.ymgme.2021.08.008_bb0575","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1542\/peds.2006-1639","article-title":"Primary care physicians' attitudes regarding follow-up care for children with positive newborn screening results","volume":"118","author":"Kemper","year":"2006","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.ymgme.2021.08.008_bb0580","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.46747\/cfp.6706e144","article-title":"Newborn screening for cystic fibrosis: role of primary care providers in caring for infants with positive screening results","volume":"67","author":"Carroll","year":"2021","journal-title":"Can. Fam. Physician"},{"key":"10.1016\/j.ymgme.2021.08.008_bb0585","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jpeds.2020.03.042","article-title":"Vulnerable child syndrome and newborn screening carrier results for cystic fibrosis or sickle cell","volume":"224","author":"Farrell","year":"2020","journal-title":"J. Pediatr."},{"issue":"9","key":"10.1016\/j.ymgme.2021.08.008_bb0590","doi-asserted-by":"crossref","first-page":"619","DOI":"10.7326\/M18-1161","article-title":"Clinical outcomes associated with sickle cell trait: a systematic review","volume":"169","author":"Naik","year":"2018","journal-title":"Ann. Intern. Med."},{"issue":"2","key":"10.1016\/j.ymgme.2021.08.008_bb0595","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1001\/archpedi.155.2.117","article-title":"Is public health ready for genetics?","volume":"155","author":"Holtzman","year":"2001","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"10.1016\/j.ymgme.2021.08.008_bb0600","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153253","article-title":"High-quality exome sequencing of whole genome amplified neonatal dried blood spot DNA","volume":"11","author":"Poulsen","year":"2016","journal-title":"PLoS One"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719221007721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719221007721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:52:43Z","timestamp":1761090763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719221007721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":117,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S1096719221007721"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2021.08.008","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenging the dogma of the healthy heterozygote: Implications for newborn screening policies and practices","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2021.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}